Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Khalil

Showing results (71-80 of 137) with videos related to

Pageof 14
Sort By:
International Journal of Molecular Sciences|March 27, 2025
Transient Global Amnesia (TGA): Is It Really Benign? A Pilot Study on Blood BiomarkersFabio Rossini, Tobias Moser, Michael Unterhofer, et al.
Journal of the Neurological Sciences|October 22, 2023
Psychological factors and brain magnetic resonance imaging metrics associated with fatigue in persons with multiple sclerosisStefanie Hechenberger, Birgit Helmlinger, Iris-Katharina Penner, et al.
Nature Reviews. Neurology|September 2, 2018
Neurofilaments as biomarkers in neurological disordersMichael Khalil, Charlotte E Teunissen, Markus Otto, et al.
The British Journal of Ophthalmology|June 24, 2022
Neurofilament light chain: a new marker for neuronal decay in the anterior chamber fluid of patients with glaucomaNora Woltsche, Katharina Valentin, Lukas Hoeflechner, et al.
Therapeutic Advances in Neurological Disorders|February 6, 2023
Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosisIlaria Callegari, Mika Schneider, Vera Aebischer, et al.
Journal of Neurology|April 9, 2026
The role of age in choosing high-efficacy treatment for multiple sclerosis: an Austrian MS Database studyHarald Hegen, Fabian Föttinger, Janette Walde, et al.
Human Brain Mapping|March 9, 2026
Time-Varying Brain Functional Reconfiguration Patterns Associated With Fatigue in Multiple SclerosisStefanie Hechenberger, Tommy A A Broeders, Marloes D A Bet, et al.
Pharmacology & Therapeutics|August 23, 2024
Targeting organ-specific mitochondrial dysfunction to improve biological agingCorina T Madreiter-Sokolowski, Ursula Hiden, Jelena Krstic, et al.
Brain : a Journal of Neurology|July 5, 2026
Propionic acid in multiple sclerosis: a phase 2b, double-blind, randomized placebo-controlled trialTobias Moser, Wolfgang Hitzl, Tiago Lerda-Casaccia, et al.
European Journal of Neurology|February 13, 2023
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosisArabella Buchmann, Lukas Pirpamer, Daniela Pinter, et al.
Pageof 14

Showing results (71-80 of 137) with videos related to

Sort By:
Pageof 14
International Journal of Molecular Sciences|March 27, 2025
Transient Global Amnesia (TGA): Is It Really Benign? A Pilot Study on Blood BiomarkersFabio Rossini, Tobias Moser, Michael Unterhofer, et al.
Journal of the Neurological Sciences|October 22, 2023
Psychological factors and brain magnetic resonance imaging metrics associated with fatigue in persons with multiple sclerosisStefanie Hechenberger, Birgit Helmlinger, Iris-Katharina Penner, et al.
Nature Reviews. Neurology|September 2, 2018
Neurofilaments as biomarkers in neurological disordersMichael Khalil, Charlotte E Teunissen, Markus Otto, et al.
The British Journal of Ophthalmology|June 24, 2022
Neurofilament light chain: a new marker for neuronal decay in the anterior chamber fluid of patients with glaucomaNora Woltsche, Katharina Valentin, Lukas Hoeflechner, et al.
Therapeutic Advances in Neurological Disorders|February 6, 2023
Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosisIlaria Callegari, Mika Schneider, Vera Aebischer, et al.
Journal of Neurology|April 9, 2026
The role of age in choosing high-efficacy treatment for multiple sclerosis: an Austrian MS Database studyHarald Hegen, Fabian Föttinger, Janette Walde, et al.
Human Brain Mapping|March 9, 2026
Time-Varying Brain Functional Reconfiguration Patterns Associated With Fatigue in Multiple SclerosisStefanie Hechenberger, Tommy A A Broeders, Marloes D A Bet, et al.
Pharmacology & Therapeutics|August 23, 2024
Targeting organ-specific mitochondrial dysfunction to improve biological agingCorina T Madreiter-Sokolowski, Ursula Hiden, Jelena Krstic, et al.
Brain : a Journal of Neurology|July 5, 2026
Propionic acid in multiple sclerosis: a phase 2b, double-blind, randomized placebo-controlled trialTobias Moser, Wolfgang Hitzl, Tiago Lerda-Casaccia, et al.
European Journal of Neurology|February 13, 2023
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosisArabella Buchmann, Lukas Pirpamer, Daniela Pinter, et al.
Pageof 14